Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors

摘要

Gastrin-dependent tumors, e.g. in colorectal adenocarcinoma, are treated by combination therapy. The combination of:(i) an antibodies to gastrin G17; and(ii) one or more chemotherapeutic agents, e.g. 5-fluorouracil and leucovorin, is suitable for this purpose.